Resources

3 Resources for

biotech and joseph ramelli

Emisphere: Why We're Confident: Joseph Ramelli submits: We recently finished buying a position in Emisphere EMIS. We have done a ton of due diligence and networked with some of the smartest biotech minds on the street and think that the stock should be trading at $5 now and that it will be well...; Tags: Biotech, Joseph Ramelli, Emisphere Technologies Inc.; External links 2009-05-17
The Emisphere Story Just Got Bigger: Joseph Ramelli submits: There has been a huge positive development in the Emisphere story that hasn’t really filtered out yet. A friend stumbled upon a patent application filed by Novartis NVS entitled “Use of Calcitonin for the Treatment of Rheumatoid Arthritis.” The patent application can be viewed here. The...; Tags: Biotech, Healthcare, Joseph Ramelli, Emisphere Technologies Inc., Novartis AG; External links 2009-07-01
Emisphere: The Most Undervalued Biotech: Joseph Ramelli submits: The FDA's clinicaltrials.gov website has some really interesting information on the European Phase III trial of Emisphere’s EMIS Oral Salmon Calcitonin for Osteoarthritis that is being run by Nordic Bioscience for Emisphere’s partner, Novartis NVS. One of the Primary...; Tags: Biotech, Joseph Ramelli, Emisphere Technologies Inc., Novartis AG; External links 2009-09-30